Sanuwave Health Overview

  • Year Founded
  • 2004

Year Founded

  • Status
  • Public

  • Employees
  • 38


  • Stock Symbol
  • SNWV

Stock Symbol

  • Investments
  • 7

  • Share Price
  • $0.02
  • (As of Friday Closing)

Sanuwave Health General Information


SANUWAVE Health Inc is an ultrasound and shock wave technology company using patented systems of noninvasive, high-energy, acoustic shock waves or low-intensity and non-contact ultrasound for regenerative medicine and other applications. The company's focus is regenerative medicine utilizing noninvasive, acoustic shock waves or ultrasound to produce a biological response resulting in the body healing itself through the repair and regeneration of tissue, musculoskeletal, and vascular structures. The company's two primary systems are UltraMIST and PACE. UltraMIST and PACE are the only two Food and Drug Administration (FDA) approved directed energy systems for wound healing.

Contact Information

Formerly Known As
HealthTronics (Orthopedic Electrocorporeal Shockwave Lithotripsy Assets)
Ownership Status
Publicly Held
Financing Status
Formerly PE-Backed
Primary Industry
Other Devices and Supplies
Other Industries
Therapeutic Devices
Other Healthcare Technology Systems
Stock Exchange
Primary Office
  • 3360 Martin Farm Road
  • Suite 100
  • Suwanee, GA 30024
  • United States
+1 (770) 000-0000

Sanuwave Health Timeline

Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Sanuwave Health Stock Performance

(As of Friday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$0.02 $0.02 $21.7M 1.03B 220K -$0.06

Sanuwave Health Financials Summary

In Thousands,
TTM 30-Jun-2023 FY 2022 31-Dec-2022 FY 2021 31-Dec-2021 FY 2020 31-Dec-2020
EV 52,297 43,716 100,508 98,494
Revenue 18,116 16,742 13,010 4,057
EBITDA (11,113) 4,793 (18,900) (27,384)
Net Income (28,913) (10,293) (27,259) (30,937)
Total Assets 19,197 19,873 18,619 23,027
Total Debt 44,172 41,106 28,117 17,578
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Sanuwave Health Valuation & Funding

Deal Type Date Amount Valuation/
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Sanuwave Health‘s full profile, request access.

Request a free trial

Sanuwave Health Comparisons

HQ Location
Total Raised
Post Valuation
SANUWAVE Health Inc is an ultrasound and shock wave technology company using patented systems of noninvasive, high-energ
Other Devices and Supplies
Suwanee, GA
38 As of 2022
000000000 0000


onsectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore
00000000000 0000000
Weßling, Germany
000 As of 0000


ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate ve
0000000000 000000000
Tägerwilen, Switzerland
000 As of 0000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Sanuwave Health Competitors (3)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Dornier MedTech Corporation Weßling, Germany 000
00000 0000000 Corporation Tägerwilen, Switzerland 000
00000000 000000 00 Venture Capital-Backed Kennesaw, GA 00 000 00000 00000 000
You’re viewing 3 of 3 competitors. Get the full list »

Sanuwave Health Patents

Sanuwave Health Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20220023607-A1 Pressure waves for vaccines, genetic modification and medical treatments Pending 21-Jul-2020 00000000000 0
US-20230125111-A1 Reprocessing of contaminated reusable devices with direct contact of pressure waves Pending 06-May-2020 000000000 0
US-20210346533-A1 Reprocessing of medical devices that are contaminated with bacteria, viruses, other pathogens, and biofilms with shockwaves, pressure waves or ultrasound systems Inactive 06-May-2020 00000000000
US-20210308001-A1 Shockwave and pressure waves for treatment of virus or bacteria-induced effects in human or animal lungs Pending 02-Apr-2020 000000000000
AU-2017387130-B2 Acoustic pressure shock waves used for personalized medical treatment of tissue conditions Active 31-Dec-2016 A61N7/00 0
To view Sanuwave Health’s complete patent history, request access »

Sanuwave Health Executive Team (12)

Name Title Board Seat Contact Info
Kevin Richardson II Chief Executive Officer & Chairman
Morgan Frank Chief Executive Officer
Lisa Sundstrom Chief Financial Officer, Finance & Chief Accounting Officer, Accounting
Peter Stegagno Chief Operating Officer
Iulian Cioanta Ph.D Chief Science and Technology Officer
You’re viewing 5 of 12 executive team members. Get the full list »

Sanuwave Health Board Members (7)

Name Representing Role Since
0. 000000000 Sanuwave Health Board Member 000 0000
0000 000000 Self Board Member 000 0000
0000 0000000 Sanuwave Health Board Member 000 0000
00000 0000000000 0 Sanuwave Health Chief Executive Officer & Chairman 000 0000
000-00000 0000000 Sanuwave Health Board Member 000 0000
You’re viewing 5 of 7 board members. Get the full list »

Sanuwave Health Signals

Growth Rate

0.80% Weekly
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers


Similarweb Unique Visitors


Majestic Referring Domains


PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Sanuwave Health Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Sanuwave Health‘s full profile, request access.

Request a free trial

Sanuwave Health Investments & Acquisitions (7)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
000 000000000 23-Aug-2023 0000000000 Special Purpose Acquisition Company (SPAC) 0. 000000
00000 0000000 14-Oct-2020 00000 0000 Distributors/Wholesale 00000 000
0000000000 (0 10-Aug-2020 000000000 0000 Buildings and Property
000000000 07-Nov-2019 00000 0000 Therapeutic Devices 00000 000
Advance Medical Technology (FKS/Sanuwave Health) 26-Jun-2018 Joint Venture Pharmaceuticals
You’re viewing 5 of 7 investments and acquisitions. Get the full list »